A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation

Transpl Int. 2023 Aug 22:36:11771. doi: 10.3389/ti.2023.11771. eCollection 2023.
No abstract available

Keywords: anti-CD38 monoclonal antibody; daratumumab; desensitization; plasma cells; presensitized kidney transplantation.

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Humans
  • Kidney Transplantation*

Substances

  • daratumumab
  • Antibodies, Monoclonal

Grants and funding

This study was supported by the Tongji Hospital Clinical Research Flagship Program (2019CR108).